摘要
目的:探索单纯放疗和放化疗同步治疗非小细胞肺癌晚期老年患者的临床价值。方法:选取2016年1月-2018年1月到笔者所在医院接受治疗的非小细胞肺癌患者80例,随机分成两组,对照组给予单纯放疗治疗,观察组给予放化疗同步治疗,对比两组患者治疗效果和不良反应发生率。结果:观察组治疗总有效率(72.50%)高于对照组(32.50%),观察组放射性食管炎、急性放射性肺炎、血液系统毒性、恶心呕吐等不良反应发生率均低于对照组,差异均有统计学意义(P<0.05)。结论:放化疗同步治疗非小细胞肺癌晚期老年患者比单纯放疗的临床价值更显著。
Objective:To explore the clinical value of simple radiotherapy and chemoradiotherapy in the treatment of advanced aged patients with non-small cell lung cancer.Method:From January 2016 to January 2018,80 patients with non-small cell lung cancer treated by the author’s hospital were selected,and were randomly divided into two groups.The control group was given radiotherapy alone,while the observation group was given concurrent radiotherapy and chemotherapy.The efficacy and incidence of adverse reactions were compared between the two groups.Result:The effective rate of treatment in the observation group was 72.50%,which was higher than 32.50%in the control group,the incidence of adverse reactions such as radiation esophagitis,acute radiation pneumonia,blood system toxicity,nausea and vomiting in the observation group were lower than those in the control group,the differences were statistically significant(P<0.05).Conclusion:The clinical value of concurrent chemoradiotherapy and radiotherapy in elderly patients with advanced non-small cell lung cancer is more significant than that of radiotherapy alone.
作者
盛源
SHENG Yuan(Luotian People’s Hospital,Luotian 438600,China)
出处
《中外医学研究》
2019年第35期141-142,共2页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
单纯放疗
放化疗同步
非小细胞肺癌晚期
临床价值
Radiotherapy alone
Concurrent radiotherapy and chemotherapy
Advanced non-small cell lung cancer
Clinical value
